ACADIA Pharmaceuticals
ACAD
#4034
Rank
S$3.81 B
Marketcap
S$22.07
Share price
-2.73%
Change (1 day)
-28.27%
Change (1 year)

P/S ratio for ACADIA Pharmaceuticals (ACAD)

P/S ratio as of November 2026 (TTM): 2.50

According to ACADIA Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.30. At the end of 2026 the company had a P/S ratio of 2.84.

P/S ratio history for ACADIA Pharmaceuticals from 2004 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.84-33.07%
20254.2532.92%
20243.19-54.86%
20237.0841.98%
20224.98-35.69%
20217.75-59.72%
202019.2-1.79%
201919.688.49%
201810.4-65.29%
201729.9-85.14%
2016202-99.66%
2015> 1000126.94%
2014> 10001220.3%
2013> 10002761.2%
201269.5151.89%
201127.62361.7%
20101.12-85.83%
20097.91-62.42%
200821.0-61.22%
200754.367.72%
200632.4113.64%
200515.1-38.86%
200424.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.59 163.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.47-0.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
13.9 458.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.42-3.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
0.9363-62.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA